Altered Desmosomal Proteins in Granulomatous Myocarditis and Potential Pathogenic Links to Arrhythmogenic Right Ventricular Cardiomyopathy
- 1 October 2011
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation: Arrhythmia and Electrophysiology
- Vol. 4 (5), 743-752
- https://doi.org/10.1161/circep.111.964890
Abstract
Background— Immunoreactive signal for the desmosomal protein plakoglobin (γ-catenin) is reduced at cardiac intercalated disks in patients with arrhythmogenic right ventricular cardiomyopathy (ARVC), a highly arrhythmogenic condition caused by mutations in genes encoding desmosomal proteins. Previously, we observed a false-positive case in which plakoglobin signal was reduced in a patient initially believed to have ARVC but who actually had cardiac sarcoidosis. Sarcoidosis can masquerade clinically as ARVC but has not been previously associated with altered desmosomal proteins. Methods and Results— We observed marked reduction in immunoreactive signal for plakoglobin at cardiac myocyte junctions in patients with sarcoidosis and giant cell myocarditis, both highly arrhythmogenic forms of myocarditis associated with granulomatous inflammation. In contrast, plakoglobin signal was not depressed in lymphocytic (nongranulomatous) myocarditis. To determine whether cytokines might promote dislocation of plakoglobin from desmosomes, we incubated cultures of neonatal rat ventricular myocytes with selected inflammatory mediators. Brief exposure to low concentrations of interleukin (IL)-17, tumor necrosis factor-α (TNF-α), and IL-6 (cytokines implicated in granulomatous myocarditis) caused translocation of plakoglobin from cell-cell junctions to intracellular sites, whereas other potent cytokines implicated in nongranulomatous myocarditis had no effect, even at much higher concentrations. We also observed myocardial expression of IL-17 and TNF-α and elevated levels of serum inflammatory mediators, including IL-6R, IL-8, monocyte chemoattractant protein 1, and macrophage inflammatory protein 1β, in patients with ARVC (all P<0.0001 compared with controls). Conclusions— The results suggest novel disease mechanisms involving desmosomal proteins in granulomatous myocarditis and implicate cytokines, perhaps derived in part from the myocardium, in disruption of desmosomal proteins and arrhythmogenesis in ARVC.Keywords
This publication has 46 references indexed in Scilit:
- Assessment of inflammation in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasiaEuropean Journal of Nuclear Medicine and Molecular Imaging, 2010
- Alterations in Janus Kinase (JAK)-Signal Transducers and Activators of Transcription (STAT) Signaling in Patients With End-Stage Dilated CardiomyopathyCirculation, 2003
- Autocrine Regulation of Myocyte Cx43 Expression by VEGFCirculation Research, 2002
- Tumor necrosis factor-alpha and myocardial remodeling in progression of heart failure: a current perspective.Cardiovascular Research, 2002
- Myocardial gene expression of leukaemia inhibitory factor, interleukin‐6 and glycoprotein 130 in end‐stage human heart failureEuropean Journal of Clinical Investigation, 2001
- Cytokines and Cytokine Receptors in Advanced Heart FailureCirculation, 2001
- Giant Cell Myocarditis in a Patient With Crohn's Disease, Treated with Etanercept – A Tumour Necrosis Factor-Alpha AntagonistCanadian Journal of Gastroenterology, 2001
- Giant cell myocarditis: Most fatal of autoimmune diseasesSeminars in Arthritis and Rheumatism, 2000
- Levels of Serum Interleukin-10 Reflect Disease Activity in Patients With Cardiac SarcoidosisJapanese Circulation Journal, 2000
- Cytokine Mediated Regulation of Interferon-Gamma-Induced Ido ActivationPublished by Springer Nature ,1999